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Abstract
Cocaine	addiction	is	a	chronically	relapsing	disorder	characterized	by	compulsive	drug-seeking	and	drug-taking	behavioursbehaviors.	Previous	studies	have	demonstrated	that	cocaine,	as	well	as	other	drugs	of	abuse,
alters	the	levels	of	lipid-based	signallingsignaling	molecules,	such	as	N-acylethanolamines	(NAEs).	Moreover,	brain	levels	of	NAEs	have	shown	sensitivity	to	cocaine	self-administration	and	extinction	training	in	rodents.	Given
this	background,	the	aim	of	this	study	was	to	investigate	the	effects	of	repeated	or	acute	administration	of	palmitoylethanolamide	(PEA),	an	endogenous	NAE,	on	psychomotor	sensitization	and	cocaine-induced	contextual
conditioning.	To	this	end,	the	potential	ability	of	repeated	PEA	administration	(1	or	10 mg/kg,	i.p.)	to	modulate	the	acquisition	of	cocaine-induced	behaviouralbehavioral	sensitization	(BS)	and	conditioned	place	preference	(CPP)
was	assessed	in	male	C57BL/6J	mice.	In	addition,	the	expression	of	cocaine-induced	BS	and	CPP	following	acute	PEA	administration	were	also	studied.	Results	showed	that	repeated	administration	of	both	doses	of	PEA	were
able	to	block	the	acquisition	of	cocaine-induced	BS.	Furthermore,	acute	administration	of	both	doses	of	PEA	was	able	to	abolish	the	expression	of	BS,	while	the	highest	dose	also	abolished	the	expression	of	cocaine-induced
CPP.	Taken	together,	these	results	indicate	that	exogenous	administration	of	PEA	attenuated	psychomotor	sensitization,	while	the	effect	of	PEA	in	cocaine-induced	CPP	depended	on	whether	PEA	was	administered	repeatedly
or	acutely.	These	findings	could	be	relevant	to	understand	the	role	that	NAEs	play	in	processes	underlying	the	development	and	maintenance	of	cocaine	addiction.
1.1	Introduction
N-acylethanolamines	(NAEs)	are	endogenous	bioactive	lipid	mediators	that	are	involved	in	a	wide	range	of	physiological	activities.	These	lipid	transmitters	are	synthesized	on	demand	from	membrane	phospholipids	called	N-
acylphosphatidylethanolamines	 (NAPEs)	 in	 the	 brain,	 and	 they	 are	 not	 stored	 in	 intracellular	 compartments	 (Hansen,	 2010;	 Rodríguez	 de	 Fonseca	 et	 al.,	 2005).	 These	 compounds	 include	 oleoylethanolamide	 (OEA)	 and
palmitoylethanolamide	(PEA),	which	bind	to	the	nuclear	peroxisome	proliferator-activated	receptor	alpha	(PPARα),	the	transient	receptor	potential	vanilloid	1	(TRPV1),	and	the	orphan	G	protein-coupled	receptors	GPR55	and	GPR119
(Godlewski	et	al.,	2009;	Hansen,	2010).	OEA	and	PEA	act	peripherally,	 through	PPARα,	as	 satiety	 signals	 that	modulate	 lipid	metabolism,	 feeding	behaviour	and	body	weight	 (Fu	 et	 al.,	 2003;	Rodríguez	 de	 Fonseca	 et	 al.,	 2001).
Substantial	evidence	has	also	shown	that	OEA	and	PEA	possess	antinociceptive	and	anti-inflammatory	effects	(D'Agostino	et	al.,	2009;	LoVerme	et	al.,	2006;	Suardíaz	et	al.,	2007),	as	well	as	neuroprotective	activity	trough	activation	of
PPARα	(Lombardi	et	al.,	2007;	Scuderi	et	al.,	2014;	Sun	and	Bennett,	2007).	In	addition	to	these	multiple	physiological	activities,	there	is	increasing	evidence	suggesting	that	OEA	and	PEA	participate	in	the	regulation	of	reward-related
behavioursbehaviors	(Fu	et	al.,	2008;	Hansen	and	Diep,	2009),	such	as	those	involved	in	addictive	behaviour	to	several	drugs	of	abuse	(Bilbao	et	al.,	2015;	Bystrowska	et	al.,	2014;	Mascia	et	al.,	2011;	Melis	et	al.,	2008).	For	instance,
cocaine	self-administration	and	extinction	training	alter	the	levels	of	NAEs,	including	OEA	and	PEA,	in	specific	regions	of	the	brain	reward	system	(Bystrowska	et	al.,	2014).	It	has	also	been	shown	that	inhibition	of	fatty	acid	amide
hydrolase	(FAAH)	(Luchicchi	et	al.,	2010),	which	increases	the	bioavailability	of	NAEs,	and	exogenous	administration	of	OEA	and	PEA	(Melis	et	al.,	2008)	block	nicotine-induced	activation	of	neurons	in	the	nucleus	accumbens	shell	and
ventral	 tegmental	 area.	 These	 effects	 are	mediated	 by	 type-1	 cannabinoid	 receptors	 (CB1)	 (Luchicchi	 et	 al.,	 2010)	 and	 PPARα	 receptors,	while	 PPARα	 agonists	 have	 also	 been	 shown	 to	modulate	 nicotine	 rewarding	 effects	 and
reinstatement	(Mascia	et	al.,	2011).	Regarding	cocaine-related	behavioursbehaviors,	recent	studies	have	demonstrated	that	OEA	is	able	to	block	the	expression	of	cocaine	conditioned	responses	induced	after	repeated	administration	of
the	drug	(Bilbao	et	al.,	2013).	Nevertheless,	as	far	as	we	know,	there	are	no	studies	on	the	potential	role	of	exogenous	administration	of	PEA	in	behaviouralbehavioral	processes	related	to	cocaine	addiction.
In	the	field	of	addiction,	animal	models	are	frequently	employed	to	study	the	cognitive	processes	related	to	drug	abuse	and	relapse.	BehaviouralBehavioral	sensitization	(BS)	and	conditioned	place	preference	(CPP)	are	two
paradigms	extensively	used	to	study	the	rewarding	effects	of	different	drugs	of	abuse	in	mice	or	rats	(Sanchis-Segura	and	Spanagel,	2006).	BS	to	cocaine,	and	to	other	psychomotor	stimulant	drugs,	is	characterized	by	a	progressive
increment	of	drug-induced	behaviouralbehavioral	responses	(e.g.	motor	activity,	stereotyped	behaviour)	throughout	the	repetitive	administration	of	the	drug	(Robinson	and	Berridge,	1993).	Sensitization	is	often	composed	of	an	initial
induction	phase	(also	called	acquisition	phase),	in	which	the	drug	is	administrated	repeatedly,	followed	by	a	withdrawal	period,	and	finally	a	re-exposure	to	the	drug	that	allows	the	expression	of	the	sensitized	response	(Pierce	and
Kalivas,	1997;	Robinson	and	Berridge,	1993).	On	the	other	hand,	when	vehicle-treated	animals	are	re-exposed	 to	 the	environment	 (e.g.	an	open	 field)	where	repeated	drug	administration	had	 taken	place,	 they	show	an	 increased
locomotor	 activity	 compared	 with	 those	 animals	 that	 did	 not	 receive	 repeated	 drug	 administration.	 This	 phenomenon,	 known	 as	 conditioned	 locomotion	 (CL),	 indicates	 that	 animals	 have	 learned	 to	 associate	 the	 environment
(conditioned	stimulus)	with	the	drug-induced	motor	response	(unconditioned	response)	developing	an	implicit	memory	(Galeano	et	al.,	2013).	The	CPP	paradigm	has	been	extensively	used	to	study	the	conditioned	rewarding	effects	of
addictive	drugs	by	repeated	pairing	drug	effects	with	an	initially	neutral	context,	resulting	in	an	explicit	memory	of	the	remembered	place	as	preferred	or	favouritefavorite	(Tzschentke,	2007).
In	 the	present	 study,	we	aimed	 to	 investigate	whether	 repeated	and	acute	PEA	administrations	were	able	 to	modulate	acquisition	and/or	expression	of	 cocaine-induced	BS,	CL	and	CPP.	Furthermore,	 in	order	 to	evaluate
whether	 the	acute	 administration	of	PEA	was	able	 to	 induce	other	behaviouralbehavioral	 effects	 that	 could	 influence	 the	 cocaine-related	behavioursbehaviors	 studied,	 exploratory	 activity,	 anxiety-like	behavioursbehaviors	 and	 general
neurological	status	were	also	assessed.
2.2	Materials	and	methods
2.1.2.1	Animals
Three-month-old	 C57BL/6	 male	 mice	 (25‐–30 g;	 Charles	 River,	 Barcelona,	 Spain)	 were	 employed	 for	 this	 study.	 Animals	 were	 single-housed	 under	 controlled	 environmental	 conditions	 [temperature	 (20 ± 2 °C);	 humidity
(40 ± 5	%),	12:12 h	light/dark	cycle	(lights	on	at	08:00 p.m.)].	Food	(standard	diet,	A04	SAFE	Panlab,	Barcelona,	Spain)	and	tap	water	were	provided	ad	libitum.	To	minimize	the	potential	stress	induced	by	injections,	each	mouse	was
handled,	 in	the	testing	room,	for	5 min	along	five	consecutive	days	before	the	beginning	of	each	experiment.	All	experiments	were	carried	out	 in	compliance	with	the	ARRIVE	(Animal	Research:	Reporting	of	 In	Vivo	Experiments)
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guidelines	and	 in	accordance	with	 the	European	Communities	Council	Directives	2010/63/UE,	90/219/CEE,	Regulation	 (EC)	N°	1946/2003	and	Spanish	National	and	Regional	Guidelines	 for	Animal	Experimentation	 (Real	Decreto
53/2013).	Experimental	protocols	were	approved	by	the	Local	Ethical	Committee	for	Animal	Research	of	the	University	of	Málaga	(Cod.	2014-0006).
2.2.2.2	Drugs
Cocaine	hydrochloride	(Sigma-Aldrich	Chemie	GmbH,	Munich,	Germany)	was	dissolved	in	physiological	saline	solution	(0.9	%	NaCl)	and	it	was	daily	prepared	before	its	use.	The	dose	of	cocaine	applied	was	20 mg/kg,	except	for
the	“priming”	injection	when	10 mg/kg	were	employed.	PEA	(Tocris	Bioscience,	Bristol,	UK)	was	dissolved	in	5	%	Tween-80	and	physiological	saline	solution.	The	doses	of	PEA	administered	were	1	or	10 mg/kg.	Since,	as	far	as	we	know,
the	effects	of	PEA	on	psychostimulant-induced	behaviors	were	not	previously	reported,	the	doses	of	PEA	were	chosen	based	on	previous	works	where	these	doses	showed	to	possess	anti-inflammatory	(Di	Paola	et	al.,	2012;	Esposito	et	al.,
2012),	anti-nociceptive	(Luongo	et	al.,	2013)	and	anti-epileptic	(Sheerin	et	al.,	2004)	effects;	being	the	first	two	the	most	well-known	properties	of	PEA.
Both	drugs	(cocaine	and	PEA)	were	injected	intraperitoneally	(i.p.)	in	a	final	volume	of	5 ml/kg	of	body	weight	and	injections	were	administered	on	the	left	or	right	side	of	the	peritoneum	alternatively.	In	every	experiment	(but
see	Section	2.5.1),	PEA	was	administered	30 min	before	each	trial	while	cocaine	was	administered	immediately	before	the	beginning	of	the	trial.
2.3.2.3	Cocaine-induced	behaviouralbehavioral	sensitization	protocol
The	behaviouralbehavioral	sensitization	protocol	was	a	modified	version	of	the	previously	described	by	Blanco	et	al.	(2016)	and	Galeano	et	al.	(2013).	The	apparatuses	used	were	four	open	field	(OF)	arenas	made	of	grey	Plexiglas
with	the	following	dimensions:	40	x	 × 40	x	 × 30 cm.	(Panlab,	Barcelona,	Spain).	Light	intensity	in	the	centre	of	the	arenas	was	60‐–75 	luxlx,	similar	to	those	employed	in	one	our	previous	studies	(Galeano	et	al.,	2013).	Mice	were	daily
habituated	to	the	testing	room	for	at	least	30 min.	Immediately	after	cocaine	or	vehicle	(saline	solution)	administration,	mice	were	individually	placed	in	the	centre	of	the	OF	and	allowed	to	freely	explore	the	apparatus	for	30 min	(trial
duration).	Every	trial	was	digitally	recorded	(Sony	DCR-SX22E)	and	later	analysedanalyzed	using	a	video-tracking	system	(Ethovision	XT	5.0.,	Noldus	Information	Technology,	Wageningen,	The	Netherlands).	The	dependent	variable	was
the	total	distance	travelledtraveled.	The	cocaine	sensitization	protocol	consisted	of	four	phases:	1)	Basal	locomotion	phase.	On	the	first	day,	each	mouse	was	injected	with	vehicle	and	received	one	trial	(30 min)	in	the	OF	to	measure
basal	locomotion;	2)	Cocaine	conditioning	phase.	From	the	second	to	the	sixth	day,	each	mouse	received	a	daily	injection	of	cocaine	(20 mg/kg)	or	vehicle	and	the	total	distance	travelledtraveled	in	the	OF	during	30 min	was	assessed.
This	phase	was	considered	as	the	pre-treatment;	3)	Cocaine	conditioned	locomotion	phase.	On	the	eighth	day,	following	one	day	of	withdrawal	(when	mice	were	left	undisturbed	in	their	home	cage),	mice	received	a	saline	injection	and
were	immediately	re-exposed	to	the	OF	for	30 min.	The	total	distance	travelledtraveled	was	considered	as	an	operationalized	measurement	of	the	cocaine-induced	CL;	4)	Cocaine	sensitization	phase.	On	the	twelfth	day,	mice	received	a
priming	injection	of	cocaine	(10 mg/kg)	and	the	total	distance	travelledtraveled	was	measured	during	30 min	to	assess	BS.
2.3.1.2.3.1	Experiment	1.	Effects	of	repeated	PEA	administration	on	the	acquisition	of	cocaine-induced	conditioned	locomotion	and
behaviouralbehavioral	sensitization
The	objective	of	this	first	experiment	was	to	evaluate	the	effects	of	repeated	administrations	of	PEA	on	the	acquisition	of	cocaine-induced	conditioned	locomotion	(CL)	and	behaviouralbehavioral	sensitization	(BS).	To	this	end,	thirty	naive	male	mice
were	randomly	assigned	to	 four	groups	(n = 7‐–8	mice	per	group)	and	the	cocaine	sensitization	protocol	described	 in	Section	2.3	was	carried	out	with	 two	modifications:	1)	 In	 the	basal	 locomotion	phase,	mice	were	administered	vehicle	or	PEA	(1	or
10 mg/kg)	(Fig.	1A);	2)	During	the	cocaine	conditioning	phase,	mice	were	injected	with	vehicle,	cocaine	(20 mg/kg)	or	cocaine	(20 mg/kg)	plus	PEA	(1	or	10 mg/kg)	(Fig.	1A).	The	rest	of	the	protocol	remained	the	same.
2.3.2.2.3.2	Experiment	2.	Effects	of	acute	PEA	administration	on	the	expression	of	cocaine-induced	conditioned	locomotion	and
behaviouralbehavioral	sensitization
The	aim	of	this	second	experiment	was	to	assess	the	effects	of	the	acute	administration	of	PEA	on	the	expression	of	BS	to	cocaine.	In	addition,	the	effects	of	acute	PEA	administration	on	cocaine-induced	CL	were	assessed.	Forty-one	naive	male
mice	were	randomly	assigned	to	 four	groups	(n = 8‐–11	mice	per	group)	and	subjected	to	 the	cocaine	sensitization	protocol	described	 in	2.3	with	 the	 following	modifications:	1)	During	the	cocaine	conditioned	 locomotion	phase,	mice	pre-treated	with
cocaine	in	the	previous	phase	(cocaine	conditioning	phase)	were	injected	with	either	vehicle	or	PEA	(1	or	10 mg/kg)	(Fig.	2A);	2)	In	the	cocaine	sensitization	phase,	mice	pre-treated	with	cocaine	during	the	cocaine	conditioning	phase	were	challenged	with
Fig.	1	Acquisition	of	conditioned	locomotion	and	behaviouralbehavioral	sensitization	to	cocaine	is	blocked	by	repeated	pre-treatment	with	PEA.	(A)	Schematic	representation	of	the	conditioned	locomotion	(CL)	and	behaviouralbehavioral	sensitization	(BS)	protocol	employed	(for	a	detailed
description	see	Sections	2.3	and	2.3.1.).	(B)	During	the	basal	locomotion	phase,	mice	administered	with	10 mg/kg	of	PEA	travelledtraveled	a	shorter	distance	than	mice	administered	with	either	vehicle	or	1 mg/kg	of	PEA.	(C)	In	the	cocaine	conditioning	phase,	all	groups	administered
with	cocaine	travelledtraveled	longer	distances	than	the	group	of	mice	administered	with	vehicle.	(D)	In	the	CL	session,	the	only	group	of	mice	that	showed	a	CL	response	was	that	pre-treated	with	cocaine,	indicating	that	pre-treatment	with	both	doses	of	PEA	blocked	the	acquisition	of
the	CL	to	cocaine.	(E)	In	the	BS	session,	mice	treated	with	a	priming	injection	of	cocaine	(10 mg/kg)	and	pre-treated	with	cocaine	(20 mg/kg),	travelledtraveled	a	longer	distance	than	the	rest	of	groups,	demonstrating	that	repeated	pre-treatment	with	PEA	blocked	the	acquisition	of
cocaine-induce	BS.	Data	are	expressed	as	the	mean ± SEM	of	7‐–8	mice	per	group.	*p <	0 .05	vs.	all	other	groups	(in	B,	D	and	E)	and	vs.	mice	administered	with	vehicle	(in	C);	&p 	<	0 .05	vs.	vehicle-pre-treated	group	(in	E).
alt-text:	Fig.	1
either	a	“priming”	dose	of	cocaine	(10 mg/kg)	or	a	“priming”	dose	of	cocaine	(10 mg/kg)	plus	PEA	(1	or	10 mg/kg);	while	every	mouse	pre-treated	with	vehicle	received	an	acute	cocaine	injection	at	the	same	dose	used	in	the	“priming”	injection	(10 mg/kg)
(Fig.	2A).
2.4.2.4	Cocaine-induced	conditioned	place	preference
The	procedures	to	assess	the	acquisition	and	expression	of	cocaine-induced	CPP	were	based	on	previous	reports	(Bilbao	et	al.,	2013;	Castilla-Ortega	et	al.,	2015;	Ribeiro	Do	Couto	et	al.,	2009;	Solinas	et	al.,	2008).	All	experiments	were
conducted	 in	 three	 spatial	 place	 preference	 apparatuses	 (Panlab,	 Barcelona,	 Spain)	 each	 one	 consisting	 of	 a	 box	 with	 two	 equally	 sized	 compartments	 (20	 x	  × 18	 x	  × 25 cm)	 interconnected	 by	 a	 rectangular	 corridor.	 All	 the
compartments	were	separated	by	manually	operated	guillotine	doors	for	cocaine	conditioning	phase.	The	compartments	were	differentiated	by	motifs	painted	on	the	walls	(dots	or	stripes),	colourscolors	(different	shades	of	grey	tones,
light	or	dark),	and	combinations	of	three-dimensional	polygons	placed	in	the	corners.	Mice	were	habituated	to	the	testing	room	for	30 min	prior	to	behaviouralbehavioral	testing.	The	CPP	paradigm	consisted	of	three	different	phases
over	six	days:	1)	Day	1:	pre-conditioning	phase	(one	session).	Each	mouse	was	injected	with	vehicle	and	immediately	placed	in	the	central	corridor	with	free	access	to	explore	both	compartments	for	20 min;	2)	Day	2‐–5:	conditioning
phase	(four	sessions	with	two	conditioning	trials	per	session).	Mice	were	daily	injected	with	20 mg/kg	of	cocaine	and	immediately	confined	in	the	cocaine-paired	compartment	for	30 min	(Positive	Conditioned	Stimulus,	CS+).	After	an
interval	of	3 	hoursh,	mice	were	injected	with	vehicle	and	confined	for	30 min	in	the	opposite	compartment	(Neutral	Conditioned	Stimulus,	CS-)	(Ribeiro	Do	Couto	et	al.,	2009;	Solinas	et	al.,	2008).	This	phase	was	considered	as	the	pre-
treatment;	 3)	Day	 6:	 Test	 phase	 (one	 session).	Mice	were	 injected	with	 vehicle	 and	 allowed	 to	 explore	 the	 entire	 apparatus	 for	 20 min	 under	 the	 same	 conditions	 as	 in	 the	 pre-conditioning	 phase	 (Fig.	 3A).	 Throughout	 the	 four
conditioning	sessions,	CS+	trials	always	 took	place	before	CS-	 trials,	and	 treatments	 (cocaine	or	vehicle)	were	counterbalanced	between	compartments.	The	 time	spent	and	 the	distance	 travelledtraveled	 in	each	compartment	was
determined	during	the	pre-conditioning	and	test	sessions.	The	CPP	score	was	defined	as	the	time	spent	in	the	cocaine-paired	compartment	minus	the	time	spent	in	the	saline-paired	compartment	(Bilbao	et	al.,	2013).	Each	trial/session
Fig.	2	Acute	PEA	treatment	reduced	the	expression	of	cocaine	conditioned	locomotion	and	abolished	the	expression	of	cocaine	sensitization.	(A)	Schematic	representation	of	the	conditioned	locomotion	(CL)	and	behaviouralbehavioral	sensitization	(BS)	protocol	employed	(for	a	detailed
description	see	Sections	2.3	and	2.3.2.).	(B)	In	the	CL	session,	all	groups	of	mice	pre-treated	with	cocaine	(20 mg/kg)	travelledtraveled	longer	distances	than	the	one	pre-treated	with	vehicle.	Moreover,	the	group	pre-treated	with	cocaine	and	acutely	treated	with	10 mg/kg	of	PEA,
travelledtraveled	a	shorter	distance	than	the	other	two	groups,	revealing	that	the	acute	treatment	with	the	highest	dose	of	PEA	reduced	the	expression	of	cocaine-induced	CL.	(C)	In	the	BS	session,	the	group	pre-treated	with	cocaine	(20 mg/kg)	that	were	administered	an	acute	priming
injection	of	cocaine	(10 mg/kg)	without	PEA,	travelledtraveled	a	longer	distance	that	the	rest	of	groups,	indicating	that	acute	PEA	treatments	were	able	to	abolish	the	expression	of	cocaine-induced	BS.	Data	are	expressed	as	the	mean ± SEM	of	8‐–11	mice	per	group.	*p <	0 .05	vs.
vehicle	pre-treated	group	(in	B)	and	vs.	the	rest	of	groups	(in	C);	&p <	0 .05	vs.	groups	pre-treated	with	cocaine	and	treated	with	either	acute	injection	of	vehicle	or	acute	injection	of	1 mg/kg	of	PEA.
alt-text:	Fig.	2
was	digitally	recorded	(Sony	DCR-SX22E)	and	behaviour	was	later	analysedanalyzed	using	Ethovision	XT	5.0	(Noldus	Information	Technology,	Wageningen,	The	Netherlands).
2.4.1.2.4.1	Experiment	3.	Effects	of	repeated	PEA	administration	on	the	acquisition	of	cocaine-induced	CPP
To	study	the	effects	of	repeated	PEA	administration	on	the	acquisition	of	cocaine-induced	CPP,	twenty-eight	naive	male	mice	were	randomly	assigned	to	three	groups	(n = 9‐–10	mice	per	group).	Thereafter,	animals	were	submitted	to	the	CPP
protocol	described	in	2.4	with	the	following	modification:	during	the	conditioning	phase,	mice	were	injected	with	either	cocaine	(20 mg/kg)	or	cocaine	(20 mg/kg)	plus	PEA	(1	or	10 mg/kg)	and	immediately	confined	in	the	corresponding	compartment	for
30 min	(CS+	trial).	CS-	trial	was	carried	out	3 h	later	as	described	in	Section	2.4	(Fig.	3A).	The	rest	of	the	protocol	remained	the	same.
2.4.2.2.4.2	Experiment	4.	Effects	of	acute	PEA	administration	on	the	expression	of	cocaine-induced	CPP
In	order	to	assess	the	effects	of	acute	PEA	administration	on	the	expression	of	cocaine-induced	CPP,	in	this	fourth	experiment	thirty-five	naive	male	mice	were	submitted	to	the	same	CPP	protocol	described	in	Section	2.4,	except	that	24 h	after	the
test	session	(test	1),	a	second	test	session	was	performed	(test	2)	(Fig.	4A).	Once	test	1	had	finished,	mice	were	randomly	assigned	to	three	groups	(n = 10‐–13	mice	per	group).	Twenty-four	hours	later,	during	test	2,	one	group	of	mice	was	treated	with
vehicle	while	the	other	two	groups	were	treated	with	vehicle	plus	PEA	(1	or	10 mg/kg)	(Fig.	4A).	The	CPP	score	was	calculated	for	both	test	sessions.
Fig.	3	Acquisition	of	cocaine-induced	conditioned	place	preference	was	not	affected	by	repeated	PEA	administration.	(A)	Schematic	representation	of	the	cocaine	conditioned	place	preference	(CPP)	protocol	employed	(for	a	detailed	description	see	Sections	2.4.	and	2.4.1.).	(B)	All
groups	of	mice	pre-treated	with	cocaine	(20 mg/kg),	regardless	whether	they	were	administered	with	PEA	or	not,	showed	higher	CPP	scores	in	the	test	session	than	in	the	pre-conditioning	phase.	(C)	All	groups	of	mice	pre-treated	with	cocaine	(20 mg/kg),	regardless	whether	they
were	administered	with	PEA	or	not,	travelledtraveled	longer	distances	in	the	CS+	compartment	during	the	test	session	than	during	the	pre-conditioning	session.	Data	are	expressed	as	the	mean ± SEM	of	9‐–10	mice	per	group.	*p <	0 .05	vs.	pre-conditioning	phase.
alt-text:	Fig.	3
2.5.2.5	Experiment	5.	Effects	of	PEA	administration	on	neurological	functions,	exploratory	activity	and	anxiety-like	behaviour
2.5.1.2.5.1	Neurological	screening
The	neurological	screening	was	performed	in	a	testing	room	in	which	animals	were	previously	habituated	for	30 min.	Twenty-four	naive	male	mice	were	randomly	divided	into	three	groups	(n = 7‐–9	mice	per	group).	Mice	were	treated	with	either
vehicle	or	PEA	(1	or	10 mg/kg)	and	a	neurological	screening	was	carried	out	5	and	30 min	later	(Fig.	5A).	To	test	sensorimotor	orientation,	coordinated	limb	movements	and	neurological	function,	mice	were	subjected	to	a	battery	of	previously	described
tests	(Björklund	et	al.,	1980;	Bures	et	al.,	1983;	Marshall	and	Teitelbaum,	1974;	Santín	et	al.,	2009).	The	following	sensory	reflexes	were	assessed:	(1)	whisker	touch,	in	which	a	toothpick	was	brought	close	to	the	animal	from	the	lower	rear	so	as	to	avoid
the	visual	field,	and	then	lightly	brushed	against	the	vibrissae;	(2)	head	shaking,	where	the	mouse	was	placed	on	a	small,	elevated	platform	and	tested	for	reaction	to	a	puff	of	air	gently	released	through	a	narrow	rubber	tube	(internal	diameter,	1 mm)	to	its
pinna;	(3)	somesthesis,	in	which	a	pin	prick	was	applied	to	six	sites	on	the	lateral	surface	of	the	animal	body,	combining	dorsal	and	ventral	placements	at	rostral,	middle	and	caudal	levels;	(4)	olfaction,	where	a	small	cotton	swab	dipped	in	ammonia	solution
was	slowly	brought	close	to	the	mouse’'s	nose	in	a	lateral-medial	direction;	(5)	corneal	reflex,	in	which	the	animal	was	restrained	with	a	hand	while	the	cornea	was	superficially	stimulated	with	a	fine,	hair-tipped	probe;	(6)	auditory	startle,	in	which	an
unexpected,	loud	acoustic	stimulus	was	applied.	Limb	reflexes	and	limb	coordination	were	assessed	using	the	following	tests:	(1)	surface	righting	reflexes,	in	which	the	animal	was	placed	on	its	back	onto	a	flat	surface,	and	the	time	for	the	animal	to	right
itself	was	measured;	(2)	Inclined	plane	test,	in	which	the	mouse	was	placed	facing	downwards	on	a	wiremesh	platform	tilted	30°,	after	which	it	was	turned	to	face	up	the	slope	and	then	was	finally	placed	on	a	horizontal	wooden	bar	(diameter,	2 cm;	length,
30 cm)	suspended	50 cm	above	the	floor,	and	its	ability	to	stay	on	the	bar	was	assessed;	(3)	extension	reflex,	where	the	mouse	was	suspended	by	its	tail	and	was	displaced	so	that	it	hung	over	the	edge.	Neurological	tests	were	rated	on	a	three-point	scale
Fig.	4	Expression	of	cocaine-induced	conditioned	place	preference	was	abolished	by	acute	PEA	administration.	(A)	Schematic	representation	of	the	cocaine	conditioned	place	preference	(CPP)	protocol	employed	(for	a	detailed	description	see	Sections	2.4.	and	2.4.2.).	(B)	The	group	of
mice	acutely	treated	with	vehicle	plus	10 mg/kg	of	PEA	during	test	2,	displayed	a	lower	CPP	score	than	during	test	1.	Moreover,	during	test	2,	this	same	group	exhibited	a	lower	CPP	score	that	the	vehicle-treated	group.	Furthermore,	a	strong	tend	toward	significance	was	observed
when	the	CPP	scores	from	test	1	and	test	2	sessions	were	compared	for	the	group	of	mice	that	was	acutely	injected	with	vehicle	plus	1 mg/kg	of	PEA.	(C)	When	distances	travelledtraveled	were	compared	between	compartments	and	test	sessions,	it	was	revealed	that	during	test	1,	all
groups	of	mice	travelledtraveled	longer	distances	in	the	CS+	than	in	the	CS-	compartment.	The	same	pattern	was	observed	during	test	2	for	groups	of	mice	acutely	treated	with	vehicle	or	vehicle	plus	1 mg/kg	of	PEA.	On	the	contrary,	the	group	of	mice	treated	with	vehicle	plus
10 mg/kg	of	PEA	travelledtraveled	similar	distances	in	both	compartments	during	test	2,	being	the	distance	travelledtraveled	in	the	CS+	compartment	shorter	than	those	travelledtraveled	by	the	other	two	groups	in	the	same	compartment.	Data	are	expressed	as	the	mean ± SEM	of	10‐–13
mice	per	group.	*p <	0 .05	vs.	test	1	(in	B)	and	vs.	CS-	compartment	in	test	2	(in	C).	&p <	0 .05	vs.	group	of	mice	injected	with	vehicle	during	test	2	(in	B)	and	vs.	the	mean	distance	travelledtraveled	in	the	CS+	compartment	by	the	group	acutely	treated	with	vehicle	plus	10 mg/kg	of	PEA
during	test	2.
alt-text:	Fig.	4
(0 = absent,	1 = weak	or	2 = strong)	presented	as	a	percentage	of	incidences	for	each	treatment	(Table	1).	Use	of	this	test	battery	allowed	us	to	determine	whether	PEA	affected	a	particular	brain	region,	interfered	with	a	specific	function	or	affected	the
central	nervous	system	as	a	whole	(Bures	et	al.,	1983).
Table	1	Neurological	screening	5	and	30 min	after	PEA	administration.
alt-text:	Table	1
Neurological	test Treatment 5 	minutesmin	post-administration 30 	minutesmin	post-administration
Absence	deficit	(0) Weak	deficit	(1) Strong	deficit	(2) Absence	deficit	(0) Weak	deficit	(1) Strong	deficit	(2)
Whisker	touch Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
PEA	10 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
Head	shaking Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
PEA	10 mg/kg 100	% ‐– ‐– 75	% 25	% ‐–
Fig.	5	The	highest	dose	of	PEA	reduced	spontaneous	exploratory	activity.	(A)	Chronological	sequence	of	the	tests	administered.	Results	from	neurological	screening	and	elevated	plus	maze	(EPM)	are	showed	in	Tables	1	and	2,	respectively.	(B)	In	the	hole	board	(HB)	test,	groups	of
mice	treated	with	vehicle	plus	10 mg/kg	of	PEA	showed	a	lower	rearing	frequency	than	groups	treated	with	vehicle	or	vehicle	plus	1 mg/kg	of	PEA.	(C)	All	groups	of	mice	exhibited	higher	head-dipping	frequencies	in	peripheral	than	in	central	holes	in	the	HB	test.	Nevertheless,	the
group	of	mice	treated	with	vehicle	plus	10 mg/kg	of	PEA	exhibited	a	lower	head-dipping	frequency	in	peripheral	holes	in	comparison	with	those	shown	by	the	other	groups.	(D)	The	same	pattern	observed	for	head-dipping	frequency	was	revealed	when	distances	travelledtraveled	were
analyzed.	Data	are	expressed	as	the	mean ± SEM	of	13‐–15	mice	per	group.	*p <	0 .05	vs.	the	other	two	groups	(in	B)	and	vs.	head-dipping	frequency	in	central	holes	(in	C)	or	distance	travelledtraveled	in	the	centre	(in	D).	&p <	0 .05	vs.	head-dipping	frequency	in	peripheral	holes	or
distance	travelledtraveled	in	periphery	zone	shown	by	groups	acutely	treated	vehicle	or	vehicle	plus	1 mg/kg	of	PEA.
alt-text:	Fig.	5
Somesthesis Vehicle 89	% 11	% ‐– 89	% ‐– 11	%
PEA	1 mg/kg 100	% ‐– ‐– 86	% 14	% ‐–
PEA	10 mg/kg 100	% ‐– ‐– 63	% ‐– 37	%
Olfaction	test Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
PEA	10 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
Corneal	reflex Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
PEA	10 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
Auditory	startle Vehicle 89	% ‐– 11	% 100	% ‐– ‐–
PEA	1 mg/kg 86	% 14	% ‐– 100	% ‐– ‐–
PEA	10 mg/kg 89	% 11	% ‐– 75	% ‐– 25	%
Righting	réflex Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
PEA	10 mg/kg 100	% ‐– ‐– 100	% ‐– ‐–
Inclined	plane	test Vehicle 89	% 11	% ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 72	% 28	% ‐–
PEA	10 mg/kg 75	% 25	% ‐– 75	% ‐– 25	%
Extension	réflex Vehicle 100	% ‐– ‐– 100	% ‐– ‐–
PEA	1 mg/kg 100	% ‐– ‐– 86	% 14	% ‐–
PEA	10 mg/kg 100	% ‐– ‐– 75	% 12.5	% 12.5	%
Results	are	expressed	as	percentage	of	mice.
2.5.2.2.5.2	Assessment	of	exploratory	and	anxiety-like	behavioursbehaviors
To	 study	 whether	 PEA	 has	 any	 effect	 on	 spontaneous	 exploratory	 activity	 and	 unconditioned	 anxiety-like	 behavioursbehaviors,	 forty-one	 naive	 male	 mice	 (not	 employed	 for	 neurological	 assessment)	 were	 randomly	 assigned	 to	 one	 of	 three
experimental	groups	(vehicle,	PEA	1	or	10 mg/kg)	(n = 13‐–15	mice	per	group)	and	subjected	to	the	hole-board	(HB)	test,	followed	twenty-four	hours	later	by	the	elevated	plus	maze	(EPM)	test	(Fig.	5A).	PEA	was	administrated	30 min	before	each	test.
2.5.2.1.2.5.2.1	Hole-board	test	The	HB	apparatus	consisted	of	an	open	box	(40	x	  × 40 cm)	surrounded	by	clear	Plexiglas	walls	(20 cm	in	height),	virtually	divided	into	a	peripheral	zone	(with	a	virtual	limit	6.5 cm	away	from	the	walls)	and	a
central	zone	that	contained	16	equidistant	holes	(5.5 cm	apart,	2.5 cm	diameter,	3 cm	depth).	Mice	were	placed	in	the	centre	of	the	HB	and	their	behaviour	was	digitally	recorded	for	5 min.	Distance	travelledtraveled	(cm)	in	peripheral	and	central	zones	was
registered	using	Ethovision	XT	5.0.	The	frequency	of	head-dipping	(the	mouse	introduced	its	nose	in	a	hole)	and	rearing	(the	mouse	stood	on	its	hind	paws,	with	forelegs	supported	or	unsupported	on	the	walls),	in	the	peripheral	and	central	zones,	were
assessed	observationally	by	a	blind	observer.
2.5.2.2.2.5.2.2	Elevated	plus	maze	test	The	EPM	apparatus	consisted	of	two	open	arms	(30 × 10 cm),	two	enclosed	arms	(30 × 10 cm	x	 × 12.5 cm),	and	a	connecting	central	platform	(5 × 5 cm).	The	maze	was	raised	to	a	height	of	57 cm	above
the	floor.	Mice	were	placed	in	the	intersection	of	the	four	arms	and	allowed	to	explore	freely	the	entire	apparatus	during	5 min.	An	arm	entry	was	counted	when	the	four	legs	of	the	mouse	entered	the	zone.	Behaviour	was	digitally	recorded	and	analyzed
observationally	by	a	blind	observer	 to	 treatments	or	using	Ethovision	XT	5.0.	The	 following	parameters	were	measured:	 frequency	of	entries	 into	both	 the	open	and	closed	arms;	 time	spent	 in	open	arms;	 latency	 to	enter	 the	open	arms;	 total	distance
travelledtraveled;	mean	velocity;	rearing,	grooming,	head-dipping	and	stretching	frequency.	Anxiety	was	assessed	by	comparing	activity	in	open	vs.	closed	arms	using	the	following	index:	time	spent	in	open	arms / (time	spent	in	open	arms + time	spent	 in
closed	arms)	(Malleret	et	al.,	1999;	Santín	et	al.,	2009).	Low	values	denoted	high	anxiety	levels.
2.6.2.6	Statistical	analysis
Results	were	expressed	as	the	mean ± SEM.	Data	were	analysedanalyzed	by	one-way	ANOVA	tests	or	by	two-	or	three-way	mixed	ANOVA	tests.	Post-hoc	multiple	comparisons	were	conducted	using	Newman-Keuls	tests.	The	total
distanced	travelledtraveled	and	the	CPP	score	in	the	test	1	of	the	experiment	4	were	analysedanalyzed	by	paired	sample	t-tests.	Data	obtained	from	the	neurological	assessment	were	analysedanalyzed	by	non-parametric	Kruskal-Wallis
tests.	The	probability	to	reject	the	null	hypothesis	was	set	at	5	%.	All	statistical	analyses	were	performed	with	STATISTICA	software	for	Windows.
3.3	Results
3.1.3.1	Experiment	1.	Repeated	PEA	administration	abolished	acquisition	of	cocaine-induced	conditioned	locomotion	and
behaviouralbehavioral	sensitization
When	basal	 locomotion	was	analysedanalyzed	during	 the	 first	day	of	 the	cocaine	sensitization	protocol,	a	one-way	ANOVA	 test	 revealed	 that	 the	group	of	mice	 treated	with	10 mg/kg	of	PEA	showed	a	 significantly	 reduced
locomotor	activity	compared	to	those	groups	treated	with	either	vehicle	or	1 mg/kg	of	PEA	(F(2,27) = 39.79,	p <	0 .001;	Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	1B).	During	the	cocaine	conditioning	phase,	a	two-way	mixed	ANOVA
test,	with	Day	(2	to	6)	as	the	within-subject	factor	and	Treatment	[(vehicle,	cocaine,	cocaine	plus	PEA	(1	or	10 mg/kg)]	as	the	between-subject	factor,	showed	that	the	main	effect	of	Treatment	and	the	interaction	Day × Treatment	were
significant	(F(3,26) = 34.14;	p <	0 .001;	F(12,104) = 2.10,	p <	0 .05,	respectively),	while	the	main	effect	of	Day	was	not	(F(4,104) = 0.54,	p = n.s.).	Newman–Keuls	post-hoc	 tests	 indicated	that,	during	each	day,	groups	that	were	administered
cocaine	travelledtraveled	significantly	longer	distances	than	the	group	that	was	administered	with	vehicle,	regardless	whether	PEA	was	administered	or	not	(p <	0 .05	for	all	comparisons)	(Fig.	1C).	These	results	revealed	that	PEA	did	not
modify	the	locomotor	activity	induced	by	repeated	administrations	of	cocaine.	During	the	cocaine	conditioned	locomotion	phase,	cocaine	pre-treated	group	exhibited	a	significantly	longer	distance	travelledtraveled	than	all	other	groups
(one-way	ANOVA	test,	F(3,26) = 6.38,	p <	0 .01;	Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	1D).	These	results	indicated	that	the	group	pre-treated	with	cocaine	acquired	cocaine-induce	CL,	while	pre-treatment	with	both	doses	of	PEA
was	able	to	block	the	acquisition	of	this	conditioned	response.	Finally,	when	mice	were	challenged	with	a	priming	dose	of	cocaine	(10 mg/kg)	(cocaine	sensitization	phase),	the	only	group	that	showed	a	significantly	longer	distance
travelledtraveled	was	the	one	pre-treated	with	cocaine	(one-way	ANOVA	test:	F(3,26) = 14.56,	p <	0 .001;	Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	1E).	This	denoted	that	pre-treatment	with	both	doses	of	PEA	was	also	able	to	block
acquisition	of	BS	to	cocaine.	Moreover,	mice	pre-treated	with	cocaine	plus	1 mg/kg	of	PEA	displayed	a	significantly	reduced	distance	travelledtraveled	compared	to	vehicle	pre-treated	mice	(Newman-Keuls	post-hoc	test,	p <	0 .05)	(Fig.
1E).
3.2.3.2	Experiment	2.	Acute	PEA	administration	reduced	the	expression	of	cocaine	induced	conditioned	locomotion	and	blocked
the	expression	of	cocaine	sensitization
During	the	cocaine	conditioning	phase,	a	two-way	mixed	ANOVA	test	revealed	that	only	the	main	effect	of	Treatment	(vehicle	or	cocaine)	was	significant	(F(1,39) = 134.05,	p <	0 .001).	Newman–Keuls	post-hoc	tests	showed	that
mice	daily	injected	with	cocaine	travelledtraveled	significantly	longer	distances	than	vehicle-injected	mice	during	the	five	days	(p <	0 .05	for	all	comparisons)	(Supplementary	Fig.	S1).	On	the	eighth	day,	a	one-way	ANOVA	test	revealed
that	cocaine	pre-treated	groups	travelledtraveled	significantly	longer	distances	than	the	vehicle	pre-treated	group	(F(3,37) = 11.16;	p <	0 .001;	Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	2B).	Interestingly,	post-hoc	tests	also	revealed	that
the	cocaine	pre-treated	group	that	was	acutely	administered	with	10 mg/kg	of	PEA	travelledtraveled	a	significantly	shorter	distance	than	other	cocaine	pre-treated	groups,	although	it	did	not	reach	the	levels	showed	by	the	group	pre-
treated	with	vehicle	(p <	0 .05	for	all	comparisons)	(Fig.	2B).	These	results	indicated	that	all	groups	pre-treated	with	cocaine	displayed	CL,	while	the	highest	dose	of	PEA	was	able	to	reduce	its	expression.	Finally,	during	the	cocaine
sensitization	phase,	a	one-way	ANOVA	test	showed	that	the	cocaine	pre-treated	group	challenged	with	a	priming	dose	of	cocaine	(10 mg/kg)	travelledtraveled	a	significantly	longer	distance	than	all	other	groups	(F(3,37) = 4.28;	p <	0 .01;
Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	2C).	Moreover,	groups	pre-treated	with	cocaine	and	challenged	with	a	priming	dose	of	cocaine	(10 mg/kg)	plus	PEA	(1	or	10 mg/kg)	showed	similar	travelledtraveled	distances	than	the	group
pre-treated	with	vehicle	and	challenged	with	cocaine	(Newman–Keuls	post-hoc	tests,	p <	0 .05)	(Fig.	2C).	These	results	demonstrated	that	the	acute	administration	of	either	dose	of	PEA,	30 min	before	the	challenge	cocaine	injection,	was
able	to	abolish	the	expression	of	cocaine-induced	BS.
3.3.3.3	Experiment	3.	Repeated	PEA	administration	did	not	interfere	with	acquisition	of	cocaine-induced	conditioned	place
preference
To	analyseanalyze	the	conditioning	phase	of	the	CPP,	a	three-way	mixed	ANOVA	test,	with	Session	(Day	2	to	5)	and	Type	of	trial	(CS+	or	CS-)	as	within-subject	factors	and	Treatment	[cocaine	(20 mg/kg)	and	cocaine	(20 mg/kg)
plus	PEA	(1	or	10 mg/kg)]	as	between-subject	factor,	was	performed.	The	analysis	revealed	that	Type	of	trial	was	the	only	main	effect	that	resulted	to	be	significant	(F(7,175) = 80.81,	p <	0 .001).	Newman–Keuls	post-hoc	tests	showed	that
in	 every	 session	 of	 the	 conditioning	 phase,	 all	 groups	 of	 mice	 travelledtraveled	 a	 significantly	 longer	 distance	 during	 the	 CS+	 trial	 than	 during	 the	 CS-	 trial,	 regardless	 of	 PEA	 administration	 (p <	 0 .05	 for	 all	 comparisons)
(Supplementary	Fig.	S2).
To	study	whether	repeated	PEA	administration	during	the	conditioning	phase	could	affect	the	CPP	acquisition,	CPP	scores	were	calculated	for	the	pre-conditioning	and	test	sessions,	and	then	a	two-way	mixed	ANOVA	test,	with
Session	(pre-conditioning	or	test)	as	the	within-subject	factor	and	Pre-treatment	[(the	type	of	treatment	received	during	the	conditioning	phase	in	the	CS+	compartment	(cocaine,	cocaine	plus	1 mg/kg	of	PEA	or	cocaine	plus	10 mg/kg
of	PEA)]	as	the	between-subject	factor,	was	carried	out.	Results	indicated	that	the	main	effect	of	Session	was	significant	(F(1,25) = 125.75,	p <	0 .001),	while	the	main	effect	of	Pre-treatment	and	the	interaction	Session × Pre-treatment
were	not	(F(2,25) = 0.55,	p = n.s.;	F(2,25) = 2.72,	p = n.s.,	 respectively).	Newman–Keuls	post-hoc	 tests	confirmed	 that	during	 the	 test	session	all	groups	of	mice	displayed	significantly	higher	CPP	scores	 than	during	 the	pre-conditioning
session	(p <	0 .05	for	all	comparisons)	(Fig.	3B).	These	results	indicated	that	all	groups	of	mice	acquired	the	CPP	regardless	whether	they	were	repeatedly	pre-treated	with	PEA	during	the	conditioning	phase	or	not.
To	further	explore	whether	repeated	PEA	administration	could	modulate	the	CPP	acquisition,	the	distances	travelledtraveled	in	the	CS+	and	CS-	compartments	during	the	pre-conditioning	and	test	sessions	were	calculated.	A
three-way	mixed	ANOVA	test	with	Session	(pre-conditioning	or	test)	and	Compartment	(CS+	or	CS-)	as	within-subject	factors,	and	Pre-treatment	(cocaine,	cocaine	plus	1 mg/kg	of	PEA	or	cocaine	plus	10 mg/kg	of	PEA)	as	the	between-
subject	factor,	revealed	that	of	mice	travelledtraveled	significantly	longer	distances	in	the	CS+	compartment	during	the	test	session	than	during	the	pre-conditioning	session	(p <	0 .05	for	all	comparisons)	(Fig.	3C).
3.4.3.4	Experiment	4.	Acute	PEA	administration	abolished	the	expression	of	cocaine-induced	conditioned	place	preference
During	the	conditioning	phase,	a	two-way	repeated	measured	ANOVA	test	[within-subject	factors:	Session	(Day	2	to	5)	and	Type	of	trial	(CS+	or	CS-)]	revealed	that	the	main	effect	of	Type	of	trial	was	significant	(F(1,68) = 83.57,
p <	0 .001).	Newman-Keuls	post-hoc	tests	indicated	that	in	every	session	mice	travelledtraveled	significantly	longer	distances	during	the	CS+	trial	than	during	the	CS-	trial	(p <	0 .05	for	all	comparisons)	(Supplementary	Fig.	S3A).	In
order	to	analyseanalyze	whether	mice	correctly	acquired	cocaine-induced	CPP	and	CL,	CPP-scores	and	total	distances	travelledtraveled	were	compared	between	pre-conditioning	and	test	1	session.	Student's	paired	t-tests	confirmed	that
all	mice	showed	a	significantly	higher	CPP	score	and	 travelledtraveled	a	significantly	 longer	distance	during	test	1	than	during	the	pre-conditioning	session	(t = 	 ‐−9.48,	d.f.	34,	p <	0 .001;	t = 	 ‐−5.04,	d.f.	 34,	p <	 0 .001,	 respectively)
(Supplementary	Fig.	S3B–C).
To	assess	the	effects	of	acute	PEA	administration	on	the	expression	of	cocaine-induced	CPP,	a	two-way	mixed	ANOVA	test,	with	Test	session	(test	1	or	test	2)	as	the	within-subject	factor	and	Treatment	(vehicle,	vehicle	plus
1 mg/kg	of	PEA	or	vehicle	plus	10 mg/kg	of	PEA)	as	the	between-subject	factor,	was	performed.	Results	revealed	that	the	main	effect	of	Test	session	as	well	as	the	interaction	Test	session × Treatment	were	both	significant	(F(1,32) = 6.90,
p <	0 .05;	F(2,32) = 6.08,	p <	0 .01,	respectively).	Newman-Keuls	post-hoc	tests	indicated	that	the	group	of	mice	that	were	administered	10 mg/kg	of	PEA	during	test	2,	showed	a	significantly	lower	CPP	score	compared	to	the	one	showed
during	test	1	(p <	0 .05)	(Fig.	4B),	while	a	strong	trend	toward	significance	(p =	0 .06)	was	observed	for	the	group	of	mice	treated	with	1 mg/kg	of	PEA.	Moreover,	CPP	score	displayed	by	mice	treated	with	10 mg/kg	of	PEA	was	also
significantly	lower	than	that	displayed	by	the	vehicle-treated	group	during	the	same	session	(test	2)	(p <	0 .05)	(Fig.	4B).	In	addition,	distances	travelledtraveled	in	each	compartment	(CS+	and	CS-)	during	test	2	were	compared	to	those
travelledtraveled	during	test	1	for	the	different	treatments.	The	three-way	mixed	ANOVA	test	[within	subject	factors:	Test	Session	(test	1	or	test	2)	and	Compartment	(CS+	or	CS-);	between-subject	factor:	Treatment	(vehicle,	vehicle	plus
1 mg/kg	of	PEA	or	 vehicle	plus	10 mg/kg	 of	 PEA]	 revealed	 that	 the	main	 effect	 of	Compartment	 and	 the	 second	order	 interaction	Test	 session × Compartment × Treatment	were	significant	 (F(1,32) = 124.43,	p <	 0 .001;	F(2,32) = 4.18,
p <	0 .05,	respectively).	Newman-Keuls	post-hoc	tests	indicated	that	all	groups	of	mice	travelledtraveled	significantly	 longer	distances	 in	the	CS+	compartment	than	in	the	CS-	compartment	during	the	test	1	session	(p <	0 .05	 for	all
comparisons)	(Fig.	4C).	On	the	contrary,	during	the	test	2	session	the	group	of	mice	acutely	treated	with	10 mg/kg	of	PEA	travelledtraveled	a	similar	distance	in	both	compartments	(p = n.s.)	(Fig.	4C).	Finally,	groups	acutely	treated	with
either	vehicle	or	1 mg/kg	of	PEA	travelledtraveled	significantly	longer	distances	in	the	CS+	compartment	than	the	group	treated	with	the	highest	dose	of	PEA	(p <	0 .05	for	both	comparisons)	(Fig.	4C).
Taken	together,	these	results	indicate	that	the	highest	dose	of	PEA	(10 mg/kg)	administered	acutely	was	able	to	abolish	the	expression	of	cocaine-induced	CPP.
3.5.3.5	Experiment	5.	Acute	administration	of	the	highest	dose	of	PEA	slightly	affected	some	neurological	functions	and	reduced
exploratory	activity
3.5.1.3.5.1	Effects	of	acute	PEA	administration	on	neurological	functions
At	5	and	30 min	after	acute	administration	of	PEA	(1	or	10 mg/kg),	a	high	preservation	of	neurological	functions	was	observed,	since	groups	of	mice	that	received	the	different	treatments	(vehicle,	1 mg/kg	of	PEA	or	10 mg/kg	of	PEA)	did	not	differ
significantly	 in	any	of	 the	sensorimotor	and	coordinated	 limb	reflexes	assessed	 (p = n.s.	 for	all	Kruskal-Wallis	 tests)	 (Table	1).	Nevertheless,	although	not	 significantly,	a	 slight	affectation	 in	somesthesis	 (H(2,	N=24) = 2.29,	p = n.s.),	 auditory	 startle	 (H(2,
N=24) = 4.18,	p = n.s.),	equilibrium	(inclined	plane	test)	(H(2,	N=24) = 2.73,	p 	= n.s.)	and	extension	reflex	(H(2,	N=23) = 2.37,	p = n.s.)	was	observed	30 min	after	the	acute	administration	of	10 mg/kg	of	PEA	(Table	1).
3.5.2.3.5.2	Effects	of	acute	PEA	administration	on	exploratory	activity	and	anxiety-like	behavioursbehaviors
One-way	ANOVA	test	followed	by	post-hoc	tests	revealed	that	acute	administration	of	10 mg/kg	of	PEA	significantly	reduced	the	rearing	frequency	in	the	HB	test	(F(2,38) = 18.77,	p <	0 .001;	Newman-Keuls,	p <	0 .05	for	all	comparisons)	(Fig.	5B).
Moreover,	 two-way	mixed	ANOVA	 tests,	with	 Zone	 (periphery	 or	 centre)	 as	 the	within-subject	 factor	 and	 Treatment	 (vehicle,	 1 mg/kg	or	10 mg/kg	 of	 PEA)	 as	 the	 between-subject	 factor,	 indicated	 that,	 for	 both	 head-dipping	 frequency	 and	 distance
travelledtraveled,	 the	main	effects	of	Zone	 (F(1,38) = 118.73,	p <	0 .001;	F(1,38) = 43.44,	p <	0 .001,	 respectively),	 Treatment	 (F(2,38) = 10.82,	p <	0 .001;	F(2,38) = 11.51,	 p <	 0 .001,	 respectively),	 and	 the	 interaction	 Zone × Treatment	 (F(2,38) = 6.31,	 p <	 0 .01;
F(2,38) = 3.34,	p <	0 .05,	respectively)	were	all	significant.	Newman–Keuls	post-hoc	tests	revealed	that	all	groups	of	mice	showed	significantly	higher	head-dipping	frequency	and	longer	distance	travelledtraveled	in	the	peripheral	zone	than	in	the	central	zone
(p <	0 .05	for	all	comparisons)	(Fig.	5C–D).	Nevertheless,	the	group	of	mice	treated	with	10 mg/kg	of	PEA	showed	significantly	lower	head-dipping	frequency	and	shorter	distance	travelledtraveled	than	the	other	groups	in	the	peripheral	zone	(p <	0 .05	for	all
comparisons)	(Fig.	5C–D).
Regarding	anxiety-like	behavioursbehaviors,	none	of	the	variables	that	operationalized	anxiety	in	the	EPM	test	differed	between	treatments	(Table	2).	However,	one-way	ANOVA	tests,	 followed	by	Newman-Keuls	post-hoc	tests,	revealed	that	the
group	of	mice	 treated	with	10 mg/kg	of	 PEA	 showed	a	 shorter	 distance	 travelledtraveled	(F(2,37) = 7.13,	p <	0 .01;	Newman-Keuls	 tests,	 p <	0 .05),	 a	 lower	 velocity	 (F(2,37) = 7.14,	 p <	 0 .01;	Newman-Keuls	 tests,	 p <	 0 .05)	 and	 a	 lower	 rearing	 frequency
(F(2,37) = 6.09,	p <	0 .01;	Newman-Keuls	tests,	p <	0 .05)	than	the	remaining	groups	(Table	2).	Finally,	stretching	frequency	differed	only	between	vehicle	and	10 mg/kg	of	PEA-treated	groups	(F(2,37) = 4.78,	p <	0 .01;	Newman-Keuls	test,	p <	0 .05)	(Table	2).
Table	2	Elevated	plus	maze	test.
alt-text:	Table	2
Treatment Elevated	plus	maze:	behavioral	parameters	(Mean ± SEM)
Open	arms Anxiety Velocity
Time	(s) Latency	(s) Entries	(n°) Index (cm/s)
Vehicle 41.09 ± 4.46 12.86 ± 5.40 12.44 ± 1.56 0.17 ± 0.02 7.74 ± 0.58
PEA	1 mg/kg 39.75 ± 5.27 2.87 ± 2.65 10.29 ± 1.48 0.16 ± 0.02 7.29 ± 0.27
PEA	10 mg/kg 35.98 ± 5.60 9.65 ± 3.44 10.50 ± 1.10 0.14 ± 0.02 6.85 ± 0.35⁎#
Locomotion	(cm) Rears	(n°) Grooming	(n°) Dips	(n°) Stretches	(n°)
Vehicle 2266.28 ± 163.76 10.44 ± 1.41 1.22 ± 0.22 10.33 ± 1.41 15.11 ± 1.12
PEA	1 mg/kg 2329.42 ± 123.16 14.43 ± 1.13 1.29 ± 0.36 12.43 ± 1.89 12.71 ± 1.13
PEA	10 mg/kg 1782.42 ± 123.67⁎# 7.40 ± 1.48⁎# 1.47 ± 0.34 7.53 ± 1.37 9.07 ± 0.71⁎
⁎ p <	0 .05	vs.	vehicle.
# p <	0 .05	vs.	1 mg/kg	of	PEA.
Overall,	these	results	indicated	that	the	treatment	with	the	highest	dose	of	PEA	reduced	general	exploratory	activity	while	neither	dose	affected	anxiety-related	behavioursbehaviors.
4.4	Discussion
The	 major	 findings	 of	 the	 present	 study	 are	 that	 repeated	 administration	 of	 PEA	 was	 able	 to	 block	 the	 acquisition	 of	 BS	 and	 CL	 to	 cocaine,	 while	 its	 acute	 administration	 reduced/abolished	 the	 expression	 of	 both
behaviouralbehavioral	responses.	Regarding	the	CPP	paradigm,	it	was	found	that	when	PEA	was	administrated	repeatedly	did	not	alter	the	acquisition	of	cocaine-induced	CPP.	Finally,	acute	administration	of	PEA	was	able	to	abolish	the
expression	of	cocaine-induced	CPP.
4.1.4.1	The	blocking	effects	of	PEA	administration	on	acquisition	and	expression	of	cocaine-induced	BS	and	CL
BS	is	the	expression	of	a	series	of	brain	neuroadaptations	as	a	consequence	of	repeated	cocaine	administration	(Blanco	et	al.,	2012;	De	Vries	et	al.,	1998;	Robinson	and	Berridge,	1993).	Since	this	process	underlie	to	the	development
and	maintenance	of	cocaine	addiction,	promoting	craving	and	relapse	(Blanco	et	al.,	2016;	De	Vries	et	al.,	1998),	finding	compounds	with	the	ability	to	modulate	it	could	be	important	for	the	development	of	potential	therapeutic	agents.
Experimental	evidence	suggests	that	neuroinflammation	of	the	central	nervous	system	(CNS)	is	involved	in	the	sensitizing	effects	of	psychostimulants	(Maeda	et	al.,	2007;	Nakajima	et	al.,	2004;	Zalcman	et	al.,	1999).	On	the	other
hand,	PEA	has	shown	to	possess	potent	anti-inflammatory	effects	in	the	CNS.	Therefore,	we	could	hypothesize	that	the	blocking	effect	of	PEA	on	cocaine-induced	BS	could	be,	in	part,	due	to	its	anti-inflammatory	effects.	In	fact,	our
group	has	previously	shown	that	OEA,	another	N-acylethanolamine	with	anti-inflammatory	effects,	was	able	to	attenuate	cocaine-induced	BS	in	a	dose-dependent	manner	(Bilbao	et	al.,	2013).	Whether	PEA	modulates	the	cocaine-induced
BS	through	its	anti-inflammatory	actions	remains	to	be	tested	in	further	studies.
Interestingly,	PEA	and	OEA	has	a	common	main	target:	PPARα	receptor	(Mattace	Raso	et	al.,	2014).	As	it	was	mentioned	above,	in	a	previous	work	from	our	group,	OEA	was	able	to	attenuate	cocaine-induced	BS.	However,	this
effect	seemed	to	be	through	a	PPARα	receptor-independent	mechanism,	since	OEA	administration	was	still	able	to	attenuated	BS	to	cocaine	in	PPARα	knock-out	mice	(Bilbao	et	al.,	2013).	This	experimental	evidence	leads	us	to	conclude
that	the	PEA	blocking	effect	on	cocaine-induced	BS	observed	in	the	present	study	is	not	very	likely	to	be	mediated	by	PPARα-dependent	mechanisms,	although	this	hypothesis	should	be	tested	in	future	studies.
The	fact	that	PEA	was	able	to	affect	acquisition	and	expression	of	cocaine-induced	CL	suggest	that	PEA	may	also	potentially	affect	cocaine-mediated	associative	learning	processes	underlying	this	conditioned	response.	In	this
regard,	we	have	also	recently	demonstrated	that	repeated	administration	of	OEA	reduces	cocaine-induced	CL,	being	this	effect	also	PPARα-independent	(Bilbao	et	al.,	2013).
In	conclusion,	further	studies	are	needed	to	determine	by	which	specific	mechanisms	PEA	and	OEA	modulate	cocaine-induced	BS	and	CL.
4.2.4.2	The	blocking	effect	of	PEA	administration	on	expression	of	cocaine-induced	CPP
Dosage,	frequency	and	route	of	administration	are	important	factors	modulating	cocaine	effects,	although	associative	learning	mechanisms	also	play	a	key	role	in	cocaine	addiction	processes	(for	example,	drug-environment
associations).	The	involvement	of	conditioned	responses	in	cocaine-seeking	behavioursbehaviors	can	be	observed	in	different	processes,	being	one	of	the	most	studied	the	CPP	paradigm	(Tzschentke,	2007).
Our	group	has	previously	reported	the	ability	of	the	analogous	structurally	lipid	OEA	to	reduce	or	suppress	the	acquisition	of	cocaine-induced	CPP	(Bilbao	et	al.,	2013).	Interestingly,	these	effects	were	not	mediated	by	PPARα-
dependent	mechanism.	However,	 in	the	present	study	we	have	demonstrated	that	PEA	did	not	affect	 the	acquisition	of	cocaine-induced	CPP.	 It	 is	 important	to	notice	that	OEA	and	PEA	exert	 their	effects	acting	on	many	different
receptors,	ion	channels	and	enzymes	(for	instance,	vanilloid	receptors,	K+	channels,	cannabinoid-like	G-coupled	receptors	GPR55	and	GPR119,	etc.)	(Godlewski	et	al.,	2009;	Hansen,	2010;	Syed	et	al.,	2012),	which	also	may	explain	their
discrepancy	effects	on	acquisition	of	cocaine-induce	CPP.	Moreover,	OEA	and	PEA	have	also	shown	to	differ	in	the	modulation	of	some	addiction-related	mood	states,	being	OEA	able	to	block	stress-induced	anhedonia	while	PEA	fails	to
block	it	(Sayd	et	al.,	2014).	Therefore,	although	OEA	and	PEA	act	through	some	shared	receptor	and	have	both	anti-inflammatory	effects,	they	seem	to	exert	differential	actions	on	addicted-related	behavioursbehaviors.
Regarding	the	blocking	effect	of	PEA	on	cocaine-induced	CPP	expression	observed	in	the	present	study,	it	was	previously	reported	that	the	administration	of	a	selective	antagonist	of	TRPV1	in	the	nucleus	accumbens	was	able
to	abolish	the	expression	of	morphine-induced	CPP	(Heng	et	al.,	2014).	Therefore,	it	seems	unlikely	that	the	activation	of	TRPV1	by	PEA	could	underlie	the	abolishment	of	the	CPP	expression	by	PEA.	However,	this	hypothesis	should	be
taken	cautiously	due	to	the	different	drugs	employed	in	both	studies.
4.3.4.3	Effects	of	PEA	administration	on	exploratory	activity,	anxiety-like	behavioursbehaviors	and	neurological	functions
In	the	present	study,	we	have	observed	that	acute	PEA	administration	did	not	affect	anxiety-like	behavioursbehaviors.	On	the	contrary,	previous	studies	have	reported	that	PEA	induced	anxiolytic	effects,	although	this	reduction
of	anxiety	was	observed	only	after	a	repeated	administration	(Crupi	et	al.,	2013;	Guida	et	al.,	2015;	Yu	et	al.,	2011).	Regarding	locomotor	activity,	PEA	administration	did	not	modify	the	normal	exploratory	pattern,	whereas	the	spontaneous
locomotor	activity	was	significantly	reduced	by	the	highest	dose	of	PEA.	This	is	consistent	with	previous	studies	using	PEA	congeners.	For	instance,	acute	administration	of	high	doses	of	AEA	reduced	a	number	of	responses	mediated
by	activation	of	TRPV1	(de	Lago	et	al.,	2004;	Panlilio	et	al.,	2009),	such	as	horizontal	locomotor	activity,	rearing	and	grooming	frequency	(Bruijnzeel	et	al.,	2016;	Romero	et	al.,	1995;	Scherma	et	al.,	2008).	In	addition,	OEA	and	the	PPARα
agonist,	WY-14643,	have	also	been	shown	to	reduce	locomotor	activity,	rearing	and	grooming	(Proulx	et	al.,	2005;	Rodríguez	de	Fonseca	et	al.,	2001).	It	is	important	to	note	that	in	the	present	study,	the	highest	dose	of	PEA	also	reduced
spontaneous	locomotor	activity	during	the	basal	locomotion	phase	in	experiment	one.	Therefore,	the	capacity	of	acute	PEA	administration	to	reduce	the	expression	of	cocaine-induced	CL	in	experiment	two	might	be	better	explained	by
PEA-induced	reduction	of	spontaneous	locomotor	activity.	However,	this	did	not	seem	to	be	the	case,	since	mice	injected	with	an	acute	dose	of	10 mg/kg	of	PEA	travelledtraveled	longer	distances	than	vehicle-treated	animals.	In	addition,
the	blocking	effect	of	acute	administration	of	PEA	on	the	expression	of	cocaine-induced	BS	could	not	be	ascribed	to	reduced	spontaneous	locomotor	activity	induced	by	10 mg/kg	of	PEA	because	this	blocking	effect	was	also	observed	in
mice	 treated	with	 1 mg/kg	 of	 PEA.	 Finally,	 the	 blocking	 effects	 of	 the	 acquisition	 of	 cocaine-induced	CL	 and	BS	 observed	 in	 experiment	 one	 could	 not	 be	 due	 to	 a	 hypothetical	 hypolocomotor	 response	 elicited	 by	 repeated	 PEA
administration,	since	it	has	been	previously	shown	that	chronic	treatment	with	10 mg/kg	of	PEA	increases	spontaneous	locomotor	activity	(Crupi	et	al.,	2013).	Furthermore,	the	abolishment	of	the	expression	of	cocaine-induced	CPP	after
acute	PEA	administration,	could	not	be	better	explained	by	the	decreased	distance	travelledtraveled	in	the	HB,	since	the	acute	injection	of	10 mg/kg	of	PEA	did	not	alter	distance	travelledtraveled	in	the	CS-	compartment.
Regarding	neurological	functions,	our	results	showed	a	preservation	of	the	evaluated	reflexes.	However,	when	the	highest	dose	of	PEA	was	administered	30 min	before	neurological	assessment,	slight	changes	in	somesthesis,
auditory	startle,	equilibrium	and	extension	reflexes	was	observed,	although	treatments	did	not	differ	statistically.	The	effects	on	somesthesis	could	be	a	consequence	of	 the	analgesic	effects	of	PEA	previously	reported	 in	rats	and
humans	(Gatti	et	al.,	2012;	Paladini	et	al.,	2016).	On	the	other	hand,	the	effects	on	limb	reflexes	could	be	ascribed	to	the	reduced	spontaneous	locomotor	activity	induced	by	the	highest	dose	of	PEA.
5.5	Conclusions
As	far	as	we	know,	 this	 is	 the	 first	study	showing	that	PEA	modulates	cocaine-induced	behaviouralbehavioral	effects.	Given	that	BS	and	CPP	are	 two	processes	relevant	 to	 the	 induction	and	maintenance	of	drug	abuse	and
dependence,	PEA	may	be	potentially	useful	to	modulate	behaviouralbehavioral	processes	related	to	cocaine	addiction.	Further	studies	are	needed	to	explore	the	neurobiological	mechanisms	underlying	these	behaviouralbehavioral	effects.
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